Assessment of hypercholesterolemia control in a managed care organization

被引:41
作者
Straka, RJ
Taheri, R
Cooper, SL
Tan, AWH
Smith, JC
机构
[1] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA
[2] HealthPartners, Bloomington, MN USA
[3] Reg Hosp, St Paul, MN USA
[4] Western Univ, Coll Pharm, Pomona, CA USA
来源
PHARMACOTHERAPY | 2001年 / 21卷 / 07期
关键词
D O I
10.1592/phco.21.9.818.34563
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To determine the extent of achievement of goal low-density lipoprotein cholesterol (LDL) as defined by National Cholesterol Education Program-Adult Treatment Panel II (NCEP-ATP II) and American Diabetes Association (ADA) 2000 guidelines, we conducted a retrospective study by integrating data from medical, laboratory, and pharmacy claims databases. Subjects were selected from a 232,000-member staff-model managed care organization consisting of 19 clinics in the Minneapolis-St. Paul, Minnesota, metropolitan area. A total of 124,971 members aged IS years and older, who had been continuously enrolled from July 1, 1996-June 6, 1998, were included. Outcome measures were the extent of achievement of goal LDL as defined by NCEP-ATP II and the use of antihyperlipidemic drugs for patients with and without diabetes at various levels of risk for coronary heart disease (CHD). Of 124,971 subjects, 6538 had a history of CHD, 1523 of whom met their LDL goal. Of the population with CHD who did not achieve goal, 1141 (43%) missed by over 30 mg/dl; 621 (54%) of these patients were not receiving drug therapy A total of 17,267 had no history of CHD but had two or more risk factors; 3298 of these achieved their LDL goal. Of those who did not achieve goal, 1136 (35%) missed by over 30 mg/dl; 897 (79%) of these were not receiving drug therapy A total of 6586 had a history of diabetes; 1004 and 2340 reached an LDL of 100 mg/dl or lower and less than 130 mg/dl, respectively Of those with diabetes who had an LDL greater than 100 mg/dl, 1276 (49%) missed their goal by over 30 mg/dl; 898 (70%) of these were not receiving drug therapy. Inadequate use of pharmacologic agents plays a significant role in failure to achieve goal LDL for patients with CHD, without CHD, and with diabetes. Analysis of the data based on the new ADA guidelines for LDL demonstrates the need for continued vigilance. Finally, the successful merging of medical, laboratory and pharmacy claims databases provides a benchmark for other institutions.
引用
收藏
页码:818 / 827
页数:10
相关论文
共 33 条
[1]   CHOLESTEROL MANAGEMENT IN PATIENTS HOSPITALIZED FOR CORONARY HEART-DISEASE [J].
BOEKELOO, BO ;
BECKER, DM ;
LEBAILLY, A ;
PEARSON, TA .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1988, 4 (03) :128-132
[2]   LOW RATE OF TREATMENT OF HYPERCHOLESTEROLEMIA BY CARDIOLOGISTS IN PATIENTS WITH SUSPECTED AND PROVEN CORONARY-ARTERY DISEASE [J].
COHEN, MV ;
BYRNE, MJ ;
LEVINE, B ;
GUTOWSKI, T ;
ADELSON, R .
CIRCULATION, 1991, 83 (04) :1294-1304
[3]   Serum cholesterol levels are underevaluated and undertreated [J].
Danias, PG ;
O'Mahony, S ;
Radford, MJ ;
Korman, L ;
Silverman, DI .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (11) :1353-+
[4]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[5]  
Ellis CJ, 1998, NEW ZEAL MED J, V111, P464
[6]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245
[7]   Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines [J].
Frolkis, JP ;
Zyzanski, SJ ;
Schwartz, JM ;
Suhan, PS .
CIRCULATION, 1998, 98 (09) :851-855
[8]   RECENT TRENDS IN THE IDENTIFICATION AND TREATMENT OF HIGH BLOOD CHOLESTEROL BY PHYSICIANS - PROGRESS AND MISSED OPPORTUNITIES [J].
GILES, WH ;
ANDA, RF ;
JONES, DH ;
SERDULA, MK ;
MERRITT, RK ;
DESTEFANO, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (09) :1133-1138
[9]  
GREENWOOD P, 1995, AM J CARDIOL, V76, P570
[10]  
GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015